BioMarin
Trade BioMarin 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BMRN
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307.
BMRN Key Statistics
Stock Snapshot
The current BioMarin(BMRN) stock price is $54.22, with a market capitalization of 10.49B. The stock trades at a price-to-earnings (P/E) ratio of 20.73.
As of 2025-11-13, BioMarin(BMRN) stock has fluctuated between $54.16 and $55.85. The current price stands at $54.22, placing the stock +0.1% above today's low and -2.9% off the high.
The BioMarin(BMRN)'s current trading volume is 2.23M, compared to an average daily volume of 2.48M.
During the past year, BioMarin(BMRN) stock moved between $50.76 at its lowest and $73.51 at its peak.
During the past year, BioMarin(BMRN) stock moved between $50.76 at its lowest and $73.51 at its peak.
BMRN News
BioMarin Pharmaceutical announced that the FDA has accepted for Priority Review its supplemental Biologics License Application to expand PALYNZIQ® treatment for...
Investors in BioMarin Pharmaceutical Inc (Symbol: BMRN) saw new options begin trading today, for the February 2026 expiration. One of the key data points that g...
BioMarin Pharmaceutical (BMRN) recently delivered its third quarter results, demonstrating ongoing revenue growth led by strong uptake of VOXZOGO and PALYNZIQ....